A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson’s disease model

As a neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP)-preferring receptor, PAC1-R mediates effective neuroprotective activity. Based on the finding that the antibiotic doxycycline (DOX) with clinical neuroprotective activity functions as a positive allosteric modulator (PAM) o...

Full description

Bibliographic Details
Main Authors: Fan Guangchun, Chen Shang, Tao Zhengxin, Zhang Huahua, Yu Rongjie
Format: Article
Language:English
Published: China Science Publishing & Media Ltd. 2022-09-01
Series:Acta Biochimica et Biophysica Sinica
Subjects:
Online Access:https://www.sciengine.com/doi/10.3724/abbs.2022126
_version_ 1797635352669716480
author Fan Guangchun
Chen Shang
Tao Zhengxin
Zhang Huahua
Yu Rongjie
author_facet Fan Guangchun
Chen Shang
Tao Zhengxin
Zhang Huahua
Yu Rongjie
author_sort Fan Guangchun
collection DOAJ
description As a neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP)-preferring receptor, PAC1-R mediates effective neuroprotective activity. Based on the finding that the antibiotic doxycycline (DOX) with clinical neuroprotective activity functions as a positive allosteric modulator (PAM) of neuropeptide PACAP receptor 1 (PAC1-R), we use virtual and laboratory screening to search for novel small molecule PAMs of PAC1-R. Virtual screening is carried out using a small-molecule library TargetMol. After two-level precision screening with Glide, the top five compounds with the best predicted affinities for PAC1-R are selected and named small positive allosteric modulator 1‒5 (SPAM1‒5). Our results show that only 4-{[4-(4-Oxo-3,4-2-yl)butanamido]methyl}benzoic acid (SPAM1) has stronger neuroprotective activity than DOX in the MPP+ PD cell model and MPTP PD mouse model. SPAM1 has a higher affinity for PAC1-R than DOX, but has no antibiotic activity. Moreover, both SPAM1 and DOX block the decrease of PAC1-R level in mouse brain tissues induced by MPTP. The successful screening of SPAM1 offers a novel drug for the treatment of neurodegenerative disease targeting the PAC1-R.
first_indexed 2024-03-11T12:20:59Z
format Article
id doaj.art-9dae328967da4a06b8658dbdef6e651f
institution Directory Open Access Journal
issn 1672-9145
language English
last_indexed 2024-03-11T12:20:59Z
publishDate 2022-09-01
publisher China Science Publishing & Media Ltd.
record_format Article
series Acta Biochimica et Biophysica Sinica
spelling doaj.art-9dae328967da4a06b8658dbdef6e651f2023-11-07T01:01:40ZengChina Science Publishing & Media Ltd.Acta Biochimica et Biophysica Sinica1672-91452022-09-01541349136410.3724/abbs.202212620d259ccA novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson’s disease modelFan Guangchun0Chen Shang1Tao Zhengxin2Zhang Huahua3Yu Rongjie4["Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou 510630, China"]["Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou 510630, China"]["Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou 510630, China"]["Department of Medical Genetics, Guangdong Medical University, Dongguan 523000, China"]["Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou 510630, China","Guangdong Province Key Laboratory of Bioengineering Medicine, Guangzhou 510630, China","Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou 510630, China","National Engineering Research Center of Genetic Medicine, Guangzhou 510630, China"]As a neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP)-preferring receptor, PAC1-R mediates effective neuroprotective activity. Based on the finding that the antibiotic doxycycline (DOX) with clinical neuroprotective activity functions as a positive allosteric modulator (PAM) of neuropeptide PACAP receptor 1 (PAC1-R), we use virtual and laboratory screening to search for novel small molecule PAMs of PAC1-R. Virtual screening is carried out using a small-molecule library TargetMol. After two-level precision screening with Glide, the top five compounds with the best predicted affinities for PAC1-R are selected and named small positive allosteric modulator 1‒5 (SPAM1‒5). Our results show that only 4-{[4-(4-Oxo-3,4-2-yl)butanamido]methyl}benzoic acid (SPAM1) has stronger neuroprotective activity than DOX in the MPP+ PD cell model and MPTP PD mouse model. SPAM1 has a higher affinity for PAC1-R than DOX, but has no antibiotic activity. Moreover, both SPAM1 and DOX block the decrease of PAC1-R level in mouse brain tissues induced by MPTP. The successful screening of SPAM1 offers a novel drug for the treatment of neurodegenerative disease targeting the PAC1-R.https://www.sciengine.com/doi/10.3724/abbs.2022126positive allosteric modulatorPACAP receptor 1doxycyclinecomputer virtual screeningneuroprotective activityParkinson’s disease
spellingShingle Fan Guangchun
Chen Shang
Tao Zhengxin
Zhang Huahua
Yu Rongjie
A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson’s disease model
Acta Biochimica et Biophysica Sinica
positive allosteric modulator
PACAP receptor 1
doxycycline
computer virtual screening
neuroprotective activity
Parkinson’s disease
title A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson’s disease model
title_full A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson’s disease model
title_fullStr A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson’s disease model
title_full_unstemmed A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson’s disease model
title_short A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson’s disease model
title_sort novel small positive allosteric modulator of neuropeptide receptor pac1 r exerts neuroprotective effects in mptp mouse parkinson s disease model
topic positive allosteric modulator
PACAP receptor 1
doxycycline
computer virtual screening
neuroprotective activity
Parkinson’s disease
url https://www.sciengine.com/doi/10.3724/abbs.2022126
work_keys_str_mv AT fanguangchun anovelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel
AT chenshang anovelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel
AT taozhengxin anovelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel
AT zhanghuahua anovelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel
AT yurongjie anovelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel
AT fanguangchun novelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel
AT chenshang novelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel
AT taozhengxin novelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel
AT zhanghuahua novelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel
AT yurongjie novelsmallpositiveallostericmodulatorofneuropeptidereceptorpac1rexertsneuroprotectiveeffectsinmptpmouseparkinsonsdiseasemodel